Looming funding cuts for one of America's major disease surveillance programs could threaten public health responses experts ...
By Christy Santhosh May 28 (Reuters) - The U.S. FDA's advisory panel recommended on Thursday that COVID-19 vaccines for ...
This fall’s updated COVID-19 vaccines should target the SARS-CoV-2 XFG variant, the US Food and Drug Administration’s (FDA’s) Vaccines and Related Biological Products Advisory Committee (VRBPAC) said ...
But advisors will take a hard look at "Cicada" variant as well ...
May 29 (Reuters) - The European Medicines Agency said on Friday COVID-19 vaccines for the 2026-27 vaccination campaign in Europe should preferably be updated to target the XFG variant. The decision ...
COVID-19 is remains a public health concern five years after the start of the pandemic. What to know about vaccines, variants and more.
Advisers to the U.S. Food and ⁠Drug ⁠Administration will discuss whether COVID-19 ⁠vaccines should be updated to target the ...
The Vaccines and Related Biological Products Advisory Committee (VRBPAC) also discussed the need to target the long-simmering ...
Add Yahoo as a preferred source to see more of our stories on Google. As a new COVID-19 variant takes over in the U.S., guidance surrounding vaccines has become increasingly confusing. Changes in ...
A new document from the European Medicines Agency (EMA) will give vaccine developers procedural guidance when the time comes for them to update COVID-19 vaccines to include protection against variant ...
Experts skipped the cicada variant BA.3.2 and last year’s LP.8.1 vaccine strain and recommended monovalent XFG option.
The Food and Drug Administration’s (FDA) advisory committee on vaccines this week will consider whether to change the ...